
Associate Director - Regulatory Affairs
Merck
Summary
The Associate Director, Regulatory Affairs Chemistry, Manufacturing, and Controls – Animal Health represents Global Regulatory Affairs Chemistry, Manufacturing, and Controls in multidisciplinary new development project teams, supporting new product development and global registration activities for the veterinary monoclonal antibody (mAb) product portfolio.
Job description
Major Activities and Responsibilities
- Veterinary mAb Technical & Regulatory Guidance: Collaborate cross-functionally with manufacturing, bioprocess development (upstream/downstream), quality, technical support, and R&D to ensure CMC regulatory and document requirements, milestones, Critical Quality Attributes, and control strategies are met for veterinary drug substance, raw materials, and finished products, aligned with FDA-CVM, EMA, USDA, and other global regulatory agencies.
- Global Veterinary Dossier Compilation & Authoring: Develop regulatory strategies and high-quality submissions; lead, author, and critically review development studies and CMC sections for new marketing authorizations and Quality Overall Summaries.
- CMC Regulatory and Technical Assessment: Provide deep CMC regulatory expertise and critically assess development, manufacture, and control of biotechnology-derived mAbs, including upstream/downstream process validation, cell bank qualification, analytical characterization, target animal potency assays, viral clearance/inactivation studies, and batch-to-batch consistency.
- Global Veterinary Registration Procedures: Serve as primary CMC regulatory liaison with global regulatory authorities for mAb products, addressing technical inquiries and monitoring registration procedures in major markets.
- Lifecycle Management & Geo-Expansion: Compile additional dossiers for geo-expansion and establish post-approval CMC maintenance strategies, including authoring veterinary variations.
- Regulatory Intelligence & Risk Mitigation: Stay informed on emerging global CMC guidelines and regulatory developments impacting monoclonal therapeutics and translate them into technical requirements and risk mitigation strategies.
- General Regulatory Tasks: Support development and maintenance of standard processes and systems to maintain regulatory information and compliance.
Education Minimum Requirement
Minimum: Master of Science (M.S.) in Biotechnology, Biochemistry, Veterinary Sciences, Biochemical Engineering, Pharmacy, Chemistry, or a related biological/life sciences discipline. Preferred: Ph.D. or D.V.M. with an advanced scientific degree in Biotechnology, Biochemistry, Veterinary Biologics, or related discipline.
Required Experience and Skills
- 5 years of relevant work experience.
- Substantial hands-on regulatory affairs CMC experience within the biopharmaceutical or animal health industry, with demonstrated and mandatory expertise in monoclonal antibodies (mAbs) or recombinant biological products.
- Strong working knowledge of global veterinary regulatory pathways, registration procedure types and quality requirements, including Veterinary CTD, VICH guidelines, EU Regulation (EU) 2019/6, USDA-CVB, and FDA-CVM regulatory frameworks.
- Deep understanding of mammalian cell culture platforms, downstream purification, bioanalytical characterization, biological potency assays, comparability studies, and adventitious agent testing.
- Proven ability to synthesize complex biotechnical and analytical data, write succinct regulatory documentation, and formulate defensible scientific justifications for regulatory authorities.
- Excellent written and oral English communication skills; demonstrated capability to influence cross-functional teams in an international matrix environment.
- Flexible, detail-oriented, and service-minded, with proven ability to collaborate effectively within a cross-functional matrix and multicultural environment.
Preferred Experience and Skills
- Direct experience interfacing with veterinary regulatory agencies (e.g., EMA CVMP Scientific Advice, FDA-CVM technical section submissions).
- Experience with target-species specific mAb design (e.g., caninized, felinized, or species-specific therapeutic antibodies).
- Experience managing biological manufacturing site transfers, scale-ups, or comparability protocols under veterinary regulatory requirements.
- Familiarity with global roll-outs and registration in global animal health markets (e.g., Latin America, Asia-Pacific, Canada, UK-VMD).
Requirements
- Minimum Master of Science (M.S.) in Biotechnology, Biochemistry, Veterinary Sciences, Biochemical Engineering, Pharmacy, Chemistry, or a related biological/life sciences discipline
- 5 years of relevant work experience
- Substantial hands-on regulatory affairs CMC experience within the biopharmaceutical or animal health industry
- Demonstrated and mandatory expertise in monoclonal antibodies (mAbs) or recombinant biological products
- Strong working knowledge of global veterinary regulatory pathways, registration procedure types and quality requirements, including Veterinary CTD, VICH guidelines, EU Regulation (EU) 2019/6, USDA-CVB, and FDA-CVM regulatory frameworks
- Deep understanding of mammalian cell culture platforms, downstream purification, bioanalytical characterization, biological potency assays, comparability studies, and adventitious agent testing
- Proven ability to synthesize complex biotechnical and analytical data, write succinct regulatory documentation, and formulate defensible scientific justifications for regulatory authorities
- Excellent written and oral English communication skills
- Demonstrated capability to influence cross-functional teams in an international matrix environment
- Flexible, detail-oriented, and service-minded with proven ability to collaborate in a cross-functional matrix and multicultural environment
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.